Ingenza and Phibro Ethanol – a division of Phibro Animal Health Corporation – have joined forces to engineer a novel yeast strain that will increase yield in the commercial production of bioethanol under both challenging and conventional environmental conditions, further driving the switch to clean biofuels.
Gates, Novo Nordisk, Wellcome foundations put $300M in global health; BioNTech stops prostate cancer study
Plus, news about EyePoint, Lyra Therapeutics and Plus Therapeutics: For global health, $300 million: The Bill & Melinda Gates Foundation, the Novo Nordisk Foundation and